Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa P van der Rijst

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 19, 2024
Reply to Sujoy KhanLisa P van der Rijst, Karin M de Winter-de Groot, Marjolein S de Bruin-Weller, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 20, 2024
Effect of dupilumab on asthma and aeroallergen sensitization in pediatric atopic dermatitis patients: Results of the BioDay registryLisa P van der Rijst, Karin M de Winter-de Groot, Nicolaas P A Zuithoff, et al.
The Journal of Dermatological Treatment|September 4, 2023
Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gapsLisa P van der Rijst, Annet van Royen-Kerkhof, Suzanne G M A Pasmans, et al.
Clinical and Translational Allergy|July 17, 2024
Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patientsLisa P van der Rijst, Michelle S Hilbrands, Nicolaas P A Zuithoff, et al.
Acta Dermato-Venereologica|August 12, 2025
Topical Steroid Withdrawal: Perspectives of Dutch Healthcare ProfessionalsFlorence Vroman, Charlotte S Schimmel, Lisa P Van der Rijst, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 16, 2025
Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and SerumLisa P van der Rijst, Edward F Knol, Nicolaas P A Zuithoff, et al.
Allergy|November 24, 2022
Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patientsLotte S Spekhorst, Lisa P van der Rijst, Marlies de Graaf, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 19, 2025
Dupilumab-Associated Ocular Surface Disease in Paediatric Atopic Dermatitis Patients: Results From the BioDay RegistryLisa P van der Rijst, Chantal M van Luijk, Sara van der Kamp, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 5, 2025
Ocular surface disease in pediatric patients with moderate-to-severe atopic dermatitisLisa P van der Rijst, Nienke Veldhuis, Sara van der Kamp, et al.
Expert Opinion on Biological Therapy|December 1, 2025
Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatmentCeleste M Boesjes, Lian F van der Gang, Roselie E Achten, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 19, 2024
Reply to Sujoy KhanLisa P van der Rijst, Karin M de Winter-de Groot, Marjolein S de Bruin-Weller, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 20, 2024
Effect of dupilumab on asthma and aeroallergen sensitization in pediatric atopic dermatitis patients: Results of the BioDay registryLisa P van der Rijst, Karin M de Winter-de Groot, Nicolaas P A Zuithoff, et al.
The Journal of Dermatological Treatment|September 4, 2023
Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gapsLisa P van der Rijst, Annet van Royen-Kerkhof, Suzanne G M A Pasmans, et al.
Clinical and Translational Allergy|July 17, 2024
Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patientsLisa P van der Rijst, Michelle S Hilbrands, Nicolaas P A Zuithoff, et al.
Acta Dermato-Venereologica|August 12, 2025
Topical Steroid Withdrawal: Perspectives of Dutch Healthcare ProfessionalsFlorence Vroman, Charlotte S Schimmel, Lisa P Van der Rijst, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 16, 2025
Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and SerumLisa P van der Rijst, Edward F Knol, Nicolaas P A Zuithoff, et al.
Allergy|November 24, 2022
Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patientsLotte S Spekhorst, Lisa P van der Rijst, Marlies de Graaf, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 19, 2025
Dupilumab-Associated Ocular Surface Disease in Paediatric Atopic Dermatitis Patients: Results From the BioDay RegistryLisa P van der Rijst, Chantal M van Luijk, Sara van der Kamp, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 5, 2025
Ocular surface disease in pediatric patients with moderate-to-severe atopic dermatitisLisa P van der Rijst, Nienke Veldhuis, Sara van der Kamp, et al.
Expert Opinion on Biological Therapy|December 1, 2025
Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatmentCeleste M Boesjes, Lian F van der Gang, Roselie E Achten, et al.
Pageof 2